Literature DB >> 27370877

Widespread Pain and Low Widespread Pain Index Scores among Fibromyalgia-positive Cases Assessed with the 2010/2011 Fibromyalgia Criteria.

Frederick Wolfe1, Niklaus Egloff2, Winfried Häuser2.   

Abstract

OBJECTIVE: Widespread pain is no longer required for fibromyalgia (FM) diagnosis according to the American College of Rheumatology (ACR) 2010 preliminary diagnostic criteria and its 2011 modification, but its absence may be of concern. We investigated whether the widespread pain definition was satisfactory and the consequences of having a small number of painful regions or of not satisfying the widespread pain criterion.
METHODS: We studied 5011 patients who satisfied the 2011 criteria. FM was identified using the Widespread Pain Index (WPI) and the Symptom Severity Scale (SSS): WPI ≥ 7 and SSS ≥ 5 or WPI 3-6 and SSS ≥ 9. Widespread pain was 4 quadrants plus axial pain, according to the 1990 ACR FM criteria.
RESULTS: There were 4700 patients (93.8%) who satisfied the ACR 1990 widespread pain criterion. Using a new strict definition for 5 pain regions based on the WPI sites, a modified widespread pain criterion requiring 4 of 5 regions identified 98.8% of criteria-positive patients. Patients without widespread pain or those in the low WPI/high SSS group had milder FM and no evidence of increased psychological or physical distress.
CONCLUSION: In usual clinical and epidemiological studies, the 2011 and 2010 criteria work well, but are not as effective in patients with asymmetrical or regional pain who do not satisfy a widespread pain criterion. A ≥ 4-pain region widespread pain definition will eliminate regional pain false-positives and will identify 98.8% of current 2011 cases. Future revisions of the 2010/2011 criteria should consider incorporating the ≥ 4-region requirement to avoid misclassification.

Entities:  

Keywords:  CRITERIA; FIBROMYALGIA; WIDESPREAD PAIN

Mesh:

Year:  2016        PMID: 27370877     DOI: 10.3899/jrheum.160153

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  Pain extent is associated with pain intensity but not with widespread pressure or thermal pain sensitivity in women with fibromyalgia syndrome.

Authors:  Marco Barbero; César Fernández-de-Las-Peñas; María Palacios-Ceña; Corrado Cescon; Deborah Falla
Journal:  Clin Rheumatol       Date:  2017-02-04       Impact factor: 2.980

2.  A comparison of the clinical manifestation and pathophysiology of myofascial pain syndrome and fibromyalgia: implications for differential diagnosis and management.

Authors:  Sheryl Bourgaize; Genevieve Newton; Dinesh Kumbhare; John Srbely
Journal:  J Can Chiropr Assoc       Date:  2018-04

3.  A picture is worth a thousand words: linking fibromyalgia pain widespreadness from digital pain drawings with pain catastrophizing and brain cross-network connectivity.

Authors:  Dan-Mikael Ellingsen; Florian Beissner; Tawfik Moher Alsady; Asimina Lazaridou; Myrella Paschali; Michael Berry; Laura Isaro; Arvina Grahl; Jeungchan Lee; Ajay D Wasan; Robert R Edwards; Vitaly Napadow
Journal:  Pain       Date:  2021-05-01       Impact factor: 7.926

4.  Baseline Characteristics of a Dyadic Cohort of Mothers With Chronic Pain and Their Children.

Authors:  Anna C Wilson; Amanda L Stone; Katrina M Poppert Cordts; Amy L Holley; Sean Mackey; Beth D Darnall; Tonya M Palermo
Journal:  Clin J Pain       Date:  2020-10       Impact factor: 3.423

5.  Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias.

Authors:  Frederick Wolfe; Brian Walitt; Serge Perrot; Johannes J Rasker; Winfried Häuser
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

6.  Potency of descending pain modulatory system is linked with peripheral sensory dysfunction in fibromyalgia: An exploratory study.

Authors:  Aline Patrícia Brietzke; Luciana Conceição Antunes; Fabiana Carvalho; Jessica Elkifury; Assunta Gasparin; Paulo Roberto Stefani Sanches; Danton Pereira da Silva Junior; Jairo Alberto Dussán-Sarria; Andressa Souza; Iraci Lucena da Silva Torres; Felipe Fregni; Wolnei Caumo Md
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

7.  CSF levels of apolipoprotein C1 and autotaxin found to associate with neuropathic pain and fibromyalgia.

Authors:  Anne-Li Lind; David Just; Maria Mikus; Claudia Fredolini; Marina Ioannou; Björn Gerdle; Bijar Ghafouri; Emmanuel Bäckryd; Lars Tanum; Torsten Gordh; Anna Månberg
Journal:  J Pain Res       Date:  2019-10-15       Impact factor: 3.133

8.  Comorbidity of Fibromyalgia in Primary Knee Osteoarthritis: Potential Impact on Functional Status and Quality of Life.

Authors:  Marwa Yahia Mahgoub; Basant Mohamed Elnady; Haytham Sayed Abdelkader; Raghdaa Abdelkhaleq Abdelhalem; Waleed Ahmed Hassan
Journal:  Open Access Rheumatol       Date:  2020-05-05

9.  Rethinking the criteria for fibromyalgia in 2019: the ABC indicators.

Authors:  Julian A Stewart; Simone Mailler-Burch; Darius Müller; Martina Studer; Roland von Känel; Martin Grosse Holtforth; Kyrill Schwegler; Niklaus Egloff
Journal:  J Pain Res       Date:  2019-07-10       Impact factor: 3.133

10.  The mapping of cortical activation by near-infrared spectroscopy might be a biomarker related to the severity of fibromyalgia symptoms.

Authors:  Daniela Gabiatti Donadel; Maxciel Zortea; Iraci L S Torres; Felipe Fregni; Wolnei Caumo
Journal:  Sci Rep       Date:  2021-08-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.